-
1
-
-
0026647845
-
Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1
-
Berman PW, Matthews TJ, Riddle L, Champe M, Hobbs MR, et al. (1992) Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. J Virol 66: 4464-9.
-
(1992)
J Virol
, vol.66
, pp. 4464-4469
-
-
Berman, P.W.1
Matthews, T.J.2
Riddle, L.3
Champe, M.4
Hobbs, M.R.5
-
2
-
-
0028024901
-
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network
-
Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, et al. (1994) Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. Jama 272: 475-80.
-
(1994)
Jama
, vol.272
, pp. 475-480
-
-
Belshe, R.B.1
Graham, B.S.2
Keefer, M.C.3
Gorse, G.J.4
Wright, P.5
-
3
-
-
19144370387
-
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1
-
Berman PW, Murthy KK, Wrin T, Vennari JC, Cobb EK, et al. (1996) Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. J Infect Dis 173: 52-9.
-
(1996)
J Infect Dis
, vol.173
, pp. 52-59
-
-
Berman, P.W.1
Murthy, K.K.2
Wrin, T.3
Vennari, J.C.4
Cobb, E.K.5
-
4
-
-
0031763443
-
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3
-
Francis DP, Gregory T, McElrath MJ, Belshe RB, Gorse GJ, et al. (1998) Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3. AIDS Res Hum Retroviruses 14: S325-31.
-
(1998)
AIDS Res Hum Retroviruses
, vol.14
-
-
Francis, D.P.1
Gregory, T.2
McElrath, M.J.3
Belshe, R.B.4
Gorse, G.J.5
-
5
-
-
0031764239
-
Development of bivalent rgp120 vaccines to prevent HIV type 1 infection
-
Berman PW, (1998) Development of bivalent rgp120 vaccines to prevent HIV type 1 infection. AIDS Res Hum Retroviruses 14: S277-89.
-
(1998)
AIDS Res Hum Retroviruses
, vol.14
-
-
Berman, P.W.1
-
6
-
-
0033527905
-
Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand
-
Berman PW, Huang W, Riddle L, Gray AM, Wrin T, et al. (1999) Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand. Virology 265: 1-9.
-
(1999)
Virology
, vol.265
, pp. 1-9
-
-
Berman, P.W.1
Huang, W.2
Riddle, L.3
Gray, A.M.4
Wrin, T.5
-
7
-
-
73349094086
-
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
-
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-20.
-
(2009)
N Engl J Med
, vol.361
, pp. 2209-2220
-
-
Rerks-Ngarm, S.1
Pitisuttithum, P.2
Nitayaphan, S.3
Kaewkungwal, J.4
Chiu, J.5
-
8
-
-
13944254982
-
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
-
Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, et al. (2005) Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 191: 654-65.
-
(2005)
J Infect Dis
, vol.191
, pp. 654-665
-
-
Flynn, N.M.1
Forthal, D.N.2
Harro, C.D.3
Judson, F.N.4
Mayer, K.H.5
-
9
-
-
33845433434
-
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
-
Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, et al. (2006) Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 194: 1661-71.
-
(2006)
J Infect Dis
, vol.194
, pp. 1661-1671
-
-
Pitisuttithum, P.1
Gilbert, P.2
Gurwith, M.3
Heyward, W.4
Martin, M.5
-
10
-
-
19944423187
-
Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays
-
Montefiori D, (2004) Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays. Current Protocols in Immunology 12.11.1-12.11.15.
-
(2004)
Current Protocols in Immunology
, pp. 1-15
-
-
Montefiori, D.1
-
11
-
-
84859393693
-
Immune-correlates analysis of an HIV-1 vaccine efficacy trial
-
Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, et al. (2012) Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 366: 1275-86.
-
(2012)
N Engl J Med
, vol.366
, pp. 1275-1286
-
-
Haynes, B.F.1
Gilbert, P.B.2
McElrath, M.J.3
Zolla-Pazner, S.4
Tomaras, G.D.5
-
12
-
-
84863932778
-
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and VAX003 HIV-1 Vaccine Efficacy Trials
-
Montefiori DC, Karnasuta C, Huang Y, Ahmed H, Gilbert P, et al. (2012) Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and VAX003 HIV-1 Vaccine Efficacy Trials. J. Infect Dis In press.
-
(2012)
J. Infect Dis In Press
-
-
Montefiori, D.C.1
Karnasuta, C.2
Huang, Y.3
Ahmed, H.4
Gilbert, P.5
-
13
-
-
34248168722
-
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate
-
Forthal DN, Gilbert PB, Landucci G, Phan T, (2007) Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. J Immunol 178: 6596-603.
-
(2007)
J Immunol
, vol.178
, pp. 6596-6603
-
-
Forthal, D.N.1
Gilbert, P.B.2
Landucci, G.3
Phan, T.4
-
14
-
-
70350306659
-
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus
-
Lai SK, Hida K, Shukair S, Wang YY, Figueiredo A, et al. (2009) Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 83: 11196-200.
-
(2009)
J Virol
, vol.83
, pp. 11196-11200
-
-
Lai, S.K.1
Hida, K.2
Shukair, S.3
Wang, Y.Y.4
Figueiredo, A.5
-
15
-
-
73949112038
-
The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1
-
Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, et al. (2009) The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 106: 20877-82.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 20877-20882
-
-
Cicala, C.1
Martinelli, E.2
McNally, J.P.3
Goode, D.J.4
Gopaul, R.5
-
16
-
-
84873444719
-
Clues emerge to explain first successful HIV vaccine trial
-
DOI: 10.1038/news.2011.541
-
Callaway E, (2011) Clues emerge to explain first successful HIV vaccine trial. NatureNews DOI: 10.1038/news.2011.541.
-
(2011)
NatureNews
-
-
Callaway, E.1
-
17
-
-
0031666180
-
An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades
-
Stamatatos L, Cheng-Mayer C, (1998) An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades. J Virol 72: 7840-5.
-
(1998)
J Virol
, vol.72
, pp. 7840-7845
-
-
Stamatatos, L.1
Cheng-Mayer, C.2
-
18
-
-
2342644898
-
The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection
-
Pinter A, Honnen WJ, He Y, Gorny MK, Zolla-Pazner S, et al. (2004) The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J Virol 78: 5205-15.
-
(2004)
J Virol
, vol.78
, pp. 5205-5215
-
-
Pinter, A.1
Honnen, W.J.2
He, Y.3
Gorny, M.K.4
Zolla-Pazner, S.5
-
19
-
-
21644446614
-
The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner
-
Saunders CJ, McCaffrey RA, Zharkikh I, Kraft Z, Malenbaum SE, et al. (2005) The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J Virol 79: 9069-80.
-
(2005)
J Virol
, vol.79
, pp. 9069-9080
-
-
Saunders, C.J.1
McCaffrey, R.A.2
Zharkikh, I.3
Kraft, Z.4
Malenbaum, S.E.5
-
20
-
-
77958115264
-
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
-
Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, et al. (2010) A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog 6: e1001028.
-
(2010)
PLoS Pathog
, vol.6
-
-
Walker, L.M.1
Simek, M.D.2
Priddy, F.3
Gach, J.S.4
Wagner, D.5
-
21
-
-
79952579682
-
Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
-
Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, et al. (2011) Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop. J Virol 85: 3128-41.
-
(2011)
J Virol
, vol.85
, pp. 3128-3141
-
-
Moore, P.L.1
Gray, E.S.2
Sheward, D.3
Madiga, M.4
Ranchobe, N.5
-
22
-
-
70349887757
-
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
-
Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326: 285-9.
-
(2009)
Science
, vol.326
, pp. 285-289
-
-
Walker, L.M.1
Phogat, S.K.2
Chan-Hui, P.Y.3
Wagner, D.4
Phung, P.5
-
23
-
-
39449098115
-
HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells
-
Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, et al. (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9: 301-9.
-
(2008)
Nat Immunol
, vol.9
, pp. 301-309
-
-
Arthos, J.1
Cicala, C.2
Martinelli, E.3
Macleod, K.4
van Ryk, D.5
-
24
-
-
0024523655
-
Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes
-
Gowda SD, Stein BS, Mohagheghpour N, Benike CJ, Engleman EG, (1989) Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol 142: 773-80.
-
(1989)
J Immunol
, vol.142
, pp. 773-780
-
-
Gowda, S.D.1
Stein, B.S.2
Mohagheghpour, N.3
Benike, C.J.4
Engleman, E.G.5
-
25
-
-
0025238945
-
HIV-1 replication is controlled at the level of T cell activation and proviral integration
-
Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA, (1990) HIV-1 replication is controlled at the level of T cell activation and proviral integration. Embo J 9: 1551-60.
-
(1990)
Embo J
, vol.9
, pp. 1551-1560
-
-
Stevenson, M.1
Stanwick, T.L.2
Dempsey, M.P.3
Lamonica, C.A.4
-
26
-
-
0025342694
-
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure
-
Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-22.
-
(1990)
Cell
, vol.61
, pp. 213-222
-
-
Zack, J.A.1
Arrigo, S.J.2
Weitsman, S.R.3
Go, A.S.4
Haislip, A.5
-
27
-
-
0027050366
-
Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates
-
Nakamura GR, Byrn R, Rosenthal K, Porter JP, Hobbs MR, et al. (1992) Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates. AIDS Res Hum Retroviruses 8: 1875-85.
-
(1992)
AIDS Res Hum Retroviruses
, vol.8
, pp. 1875-1885
-
-
Nakamura, G.R.1
Byrn, R.2
Rosenthal, K.3
Porter, J.P.4
Hobbs, M.R.5
-
28
-
-
0027170414
-
Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1
-
Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, et al. (1993) Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. J Virol 67: 6179-91.
-
(1993)
J Virol
, vol.67
, pp. 6179-6191
-
-
Nakamura, G.R.1
Byrn, R.2
Wilkes, D.M.3
Fox, J.A.4
Hobbs, M.R.5
-
29
-
-
44649102135
-
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
-
Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 7552-7557
-
-
Keele, B.F.1
Giorgi, E.E.2
Salazar-Gonzalez, J.F.3
Decker, J.M.4
Pham, K.T.5
-
30
-
-
0025827596
-
B lymphocyte fibronectin receptors: expression and utilization
-
Stupack DG, Stewart S, Carter WG, Wayner EA, Wilkins JA, (1991) B lymphocyte fibronectin receptors: expression and utilization. Scand J Immunol 34: 761-9.
-
(1991)
Scand J Immunol
, vol.34
, pp. 761-769
-
-
Stupack, D.G.1
Stewart, S.2
Carter, W.G.3
Wayner, E.A.4
Wilkins, J.A.5
-
31
-
-
0028321412
-
Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes
-
Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazarovits AI, et al. (1994) Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol 153: 517-28.
-
(1994)
J Immunol
, vol.153
, pp. 517-528
-
-
Erle, D.J.1
Briskin, M.J.2
Butcher, E.C.3
Garcia-Pardo, A.4
Lazarovits, A.I.5
-
32
-
-
16244419386
-
Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
-
Gorny MK, Stamatatos L, Volsky B, Revesz K, Williams C, et al. (2005) Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J Virol 79: 5232-7.
-
(2005)
J Virol
, vol.79
, pp. 5232-5237
-
-
Gorny, M.K.1
Stamatatos, L.2
Volsky, B.3
Revesz, K.4
Williams, C.5
-
33
-
-
77954100808
-
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
-
Zolla-Pazner S, Cardozo T, (2010) Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol 10: 527-35.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 527-535
-
-
Zolla-Pazner, S.1
Cardozo, T.2
-
34
-
-
83455254775
-
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
-
McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, et al. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480: 336-43.
-
(2011)
Nature
, vol.480
, pp. 336-343
-
-
McLellan, J.S.1
Pancera, M.2
Carrico, C.3
Gorman, J.4
Julien, J.P.5
-
35
-
-
80052938385
-
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
-
Bonsignori M, Hwang KK, Chen X, Tsao CY, Morris L, et al. (2011) Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors. J Virol 85: 9998-10009.
-
(2011)
J Virol
, vol.85
, pp. 9998-10009
-
-
Bonsignori, M.1
Hwang, K.K.2
Chen, X.3
Tsao, C.Y.4
Morris, L.5
-
36
-
-
84872500976
-
Analysis of the V2 Antibody Response Induced in Vaccinees Participating in the ALVAC/AIDSVAX HIV-1 Clinical Vaccine Trial
-
Zolla-Pazner S, DeCamp A, Cardozo T, Karasavvas N, Gottardo R, et al. (2012) Analysis of the V2 Antibody Response Induced in Vaccinees Participating in the ALVAC/AIDSVAX HIV-1 Clinical Vaccine Trial. J Virol In press.
-
(2012)
J Virol In Press
-
-
Zolla-Pazner, S.1
DeCamp, A.2
Cardozo, T.3
Karasavvas, N.4
Gottardo, R.5
-
37
-
-
77957940271
-
Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus
-
O'Rourke SM, Schweighardt B, Phung P, Fonseca DP, Terry K, et al. (2010) Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus. J Virol 84: 11200-9.
-
(2010)
J Virol
, vol.84
, pp. 11200-11209
-
-
O'Rourke, S.M.1
Schweighardt, B.2
Phung, P.3
Fonseca, D.P.4
Terry, K.5
-
38
-
-
0032543307
-
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
-
Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-59.
-
(1998)
Nature
, vol.393
, pp. 648-659
-
-
Kwong, P.D.1
Wyatt, R.2
Robinson, J.3
Sweet, R.W.4
Sodroski, J.5
-
39
-
-
27744597054
-
Structure of a V3-containing HIV-1 gp120 core
-
Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, et al. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310: 1025-8.
-
(2005)
Science
, vol.310
, pp. 1025-1028
-
-
Huang, C.C.1
Tang, M.2
Zhang, M.Y.3
Majeed, S.4
Montabana, E.5
-
40
-
-
0026595148
-
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
-
Fung MS, Sun CR, Gordon WL, Liou RS, Chang TW, et al. (1992) Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J Virol 66: 848-56.
-
(1992)
J Virol
, vol.66
, pp. 848-856
-
-
Fung, M.S.1
Sun, C.R.2
Gordon, W.L.3
Liou, R.S.4
Chang, T.W.5
-
41
-
-
0027199489
-
Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120
-
McKeating JA, Shotton C, Cordell J, Graham S, Balfe P, et al. (1993) Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J Virol 67: 4932-44.
-
(1993)
J Virol
, vol.67
, pp. 4932-4944
-
-
McKeating, J.A.1
Shotton, C.2
Cordell, J.3
Graham, S.4
Balfe, P.5
-
42
-
-
0027278133
-
A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1
-
Moore JP, (1993) A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1. J Virol 67: 3656-9.
-
(1993)
J Virol
, vol.67
, pp. 3656-3659
-
-
Moore, J.P.1
-
43
-
-
0028027741
-
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1
-
Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, et al. (1994) Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J Virol 68: 8312-20.
-
(1994)
J Virol
, vol.68
, pp. 8312-8320
-
-
Gorny, M.K.1
Moore, J.P.2
Conley, A.J.3
Karwowska, S.4
Sodroski, J.5
-
44
-
-
0028924753
-
Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein
-
Shotton C, Arnold C, Sattentau Q, Sodroski J, McKeating JA, (1995) Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 69: 222-30.
-
(1995)
J Virol
, vol.69
, pp. 222-230
-
-
Shotton, C.1
Arnold, C.2
Sattentau, Q.3
Sodroski, J.4
McKeating, J.A.5
-
45
-
-
0028965263
-
Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain
-
Wu Z, Kayman SC, Honnen W, Revesz K, Chen H, et al. (1995) Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J Virol 69: 2271-8.
-
(1995)
J Virol
, vol.69
, pp. 2271-2278
-
-
Wu, Z.1
Kayman, S.C.2
Honnen, W.3
Revesz, K.4
Chen, H.5
-
46
-
-
0029891454
-
Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site
-
Vijh-Warrier S, Pinter A, Honnen WJ, Tilley SA, (1996) Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site. J Virol 70: 4466-73.
-
(1996)
J Virol
, vol.70
, pp. 4466-4473
-
-
Vijh-Warrier, S.1
Pinter, A.2
Honnen, W.J.3
Tilley, S.A.4
-
47
-
-
33846556067
-
Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence
-
Honnen WJ, Krachmarov C, Kayman SC, Gorny MK, Zolla-Pazner S, et al. (2007) Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence. J Virol 81: 1424-32.
-
(2007)
J Virol
, vol.81
, pp. 1424-1432
-
-
Honnen, W.J.1
Krachmarov, C.2
Kayman, S.C.3
Gorny, M.K.4
Zolla-Pazner, S.5
-
48
-
-
33646146379
-
GP120: target for neutralizing HIV-1 antibodies
-
Pantophlet R, Burton DR, (2006) GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739-69.
-
(2006)
Annu Rev Immunol
, vol.24
, pp. 739-769
-
-
Pantophlet, R.1
Burton, D.R.2
-
49
-
-
80053132436
-
Broad neutralization coverage of HIV by multiple highly potent antibodies
-
Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, et al. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature.
-
(2011)
Nature
-
-
Walker, L.M.1
Huber, M.2
Doores, K.J.3
Falkowska, E.4
Pejchal, R.5
-
50
-
-
13944250922
-
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
-
Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, et al. (2005) Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis 191: 666-77.
-
(2005)
J Infect Dis
, vol.191
, pp. 666-677
-
-
Gilbert, P.B.1
Peterson, M.L.2
Follmann, D.3
Hudgens, M.G.4
Francis, D.P.5
-
51
-
-
18744394633
-
The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates
-
Pinter A, Honnen WJ, D'Agostino P, Gorny MK, Zolla-Pazner S, et al. (2005) The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates. J Virol 79: 6909-17.
-
(2005)
J Virol
, vol.79
, pp. 6909-6917
-
-
Pinter, A.1
Honnen, W.J.2
D'Agostino, P.3
Gorny, M.K.4
Zolla-Pazner, S.5
-
52
-
-
0023885197
-
Envelope sequences of two new United States HIV-1 isolates
-
Gurgo C, Guo HG, Franchini G, Aldovini A, Collalti E, et al. (1988) Envelope sequences of two new United States HIV-1 isolates. Virology 164: 531-6.
-
(1988)
Virology
, vol.164
, pp. 531-536
-
-
Gurgo, C.1
Guo, H.G.2
Franchini, G.3
Aldovini, A.4
Collalti, E.5
-
53
-
-
0021915799
-
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus
-
Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, et al. (1985) Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 313: 450-8.
-
(1985)
Nature
, vol.313
, pp. 450-458
-
-
Muesing, M.A.1
Smith, D.H.2
Cabradilla, C.D.3
Benton, C.V.4
Lasky, L.A.5
-
54
-
-
0025292252
-
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
-
Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, et al. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265: 10373-82.
-
(1990)
J Biol Chem
, vol.265
, pp. 10373-10382
-
-
Leonard, C.K.1
Spellman, M.W.2
Riddle, L.3
Harris, R.J.4
Thomas, J.N.5
-
55
-
-
0016587194
-
Recent progress in the peroxidase-labeled antibody method
-
Nakane PK, (1975) Recent progress in the peroxidase-labeled antibody method. Ann N Y Acad Sci 254: 203-11.
-
(1975)
Ann N Y Acad Sci
, vol.254
, pp. 203-211
-
-
Nakane, P.K.1
-
56
-
-
0031201061
-
Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1
-
Tidswell M, Pachynski R, Wu SW, Qiu SQ, Dunham E, et al. (1997) Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol 159: 1497-505.
-
(1997)
J Immunol
, vol.159
, pp. 1497-1505
-
-
Tidswell, M.1
Pachynski, R.2
Wu, S.W.3
Qiu, S.Q.4
Dunham, E.5
-
57
-
-
2642699794
-
Rapid and efficient site-specific mutagenesis without phenotypic selection
-
Kunkel TA, (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A 82: 488-92.
-
(1985)
Proc Natl Acad Sci U S A
, vol.82
, pp. 488-492
-
-
Kunkel, T.A.1
-
58
-
-
0015847039
-
A new technique for the assay of infectivity of human adenovirus 5 DNA
-
Graham FL, van der Eb AJ, (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-67.
-
(1973)
Virology
, vol.52
, pp. 456-467
-
-
Graham, F.L.1
van der Eb, A.J.2
-
59
-
-
0030877108
-
Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers
-
Berman PW, Gray AM, Wrin T, Vennari JC, Eastman DJ, et al. (1997) Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers. J Infect Dis 176: 384-97.
-
(1997)
J Infect Dis
, vol.176
, pp. 384-397
-
-
Berman, P.W.1
Gray, A.M.2
Wrin, T.3
Vennari, J.C.4
Eastman, D.J.5
-
60
-
-
74549175896
-
Phylodynamics of HIV-1 from a phase-III AIDS vaccine trial in North America
-
Perez-Losada M, Jobes DV, Sinangil F, Crandall KA, Posada D, et al. (2010) Phylodynamics of HIV-1 from a phase-III AIDS vaccine trial in North America. Mol Biol Evol 27: 417-25.
-
(2010)
Mol Biol Evol
, vol.27
, pp. 417-425
-
-
Perez-Losada, M.1
Jobes, D.V.2
Sinangil, F.3
Crandall, K.A.4
Posada, D.5
|